CNSX:WRLD.U

Stock Analysis Report

Executive Summary

ICC International Cannabis Corp., through its subsidiaries, engages in the cannabis business in Canada and internationally.

Snowflake

Fundamentals

Imperfect balance sheet and overvalued.

Share Price & News

How has ICC International Cannabis's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

WRLD.U

0.8%

CA Pharmaceuticals

0.2%

CA Market


1 Year Return

-95.5%

WRLD.U

-57.9%

CA Pharmaceuticals

1.2%

CA Market

Return vs Industry: WRLD.U underperformed the Canadian Pharmaceuticals industry which returned -57.9% over the past year.

Return vs Market: WRLD.U underperformed the Canadian Market which returned 1.2% over the past year.


Shareholder returns

WRLD.UIndustryMarket
7 Day0%0.8%0.2%
30 Day-36.4%-23.6%-2.5%
90 Day-63.2%-34.0%-1.5%
1 Year-95.5%-95.5%-57.9%-57.9%4.7%1.2%
3 Year-30.0%-30.0%77.3%76.0%14.0%3.8%
5 Yearn/a280.0%280.0%26.4%8.1%

Price Volatility Vs. Market

How volatile is ICC International Cannabis's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ICC International Cannabis undervalued compared to its fair value and its price relative to the market?

0.21x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate WRLD.U's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate WRLD.U's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: WRLD.U is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.

PE vs Market: WRLD.U is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate WRLD.U's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: WRLD.U is good value based on its PB Ratio (0.2x) compared to the CA Pharmaceuticals industry average (1.9x).


Next Steps

Future Growth

How is ICC International Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

87.4%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICC International Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has ICC International Cannabis performed over the past 5 years?

-98.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: WRLD.U is unprofitable, and losses have increased over the past 5 years at a rate of -98% per year.

Accelerating Growth: Unable to compare WRLD.U's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WRLD.U is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (15.6%).


Return on Equity

High ROE: WRLD.U has a negative Return on Equity (-77.47%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: WRLD.U is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: WRLD.U is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is ICC International Cannabis's financial position?


Financial Position Analysis

Short Term Liabilities: WRLD.U's short term assets (CA$12.9M) exceeds its short term liabilities (CA$844.9K)

Long Term Liabilities: WRLD.U's short term assets (12.9M) do not cover its long term liabilities (28.4M)


Debt to Equity History and Analysis

Debt Level: WRLD.U's debt to equity ratio (19.4%) is considered satisfactory

Reducing Debt: Insufficient data to determine if WRLD.U's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: WRLD.U has a low level of unsold assets or inventory.

Debt Coverage by Assets: WRLD.U's debt is not covered by short term assets (assets are 0.5x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WRLD.U has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if WRLD.U has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is ICC International Cannabis's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.9%industryaverage2.8%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate WRLD.U's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate WRLD.U's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if WRLD.U's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if WRLD.U's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of WRLD.U's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of ICC International Cannabis's salary, the management and board of directors tenure and is there insider trading?

0.5yrs

Average management tenure


CEO

David Shpilt (40yo)

0.5yrs

Tenure

0

Mr. David Shpilt serves as Chief Executive Officer and Director of Patient Services at Plants Not Pills. Mr. Shpilt serves as a Chief Executive Officer at ICC International Cannabis Corp. since joined it  ...


Management Age and Tenure

0.5yrs

Average Tenure

Experienced Management: WRLD.U's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Age and Tenure

1.4yrs

Average Tenure

Experienced Board: WRLD.U's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Catherine McClusky (66yo)

    Consultant

    • Tenure: 5.5yrs
    • Compensation: CA$1.71k
  • David Shpilt (40yo)

    Chief Executive Officer

    • Tenure: 0.5yrs
  • Peter Nguyen

    CFO & Director

    • Tenure: 0.3yrs
  • Jonathan Beland

    Vice President of Corporate Development

    • Tenure: 0.5yrs
  • Lauren Magda

    Chief of Staff

    • Tenure: 0.5yrs

Board Members

  • Eugene Beukman (61yo)

    Director

    • Tenure: 1.5yrs
  • Stacy Quinney (49yo)

    Member of Advisory Board

    • Tenure: 3.7yrs
  • Brendan Purdy

    Director

    • Tenure: 1.3yrs
  • Julio Viskovich

    Member of Advisory Board

    • Tenure: 4.9yrs
  • Neill Franklin

    Member of Advisory Board

    • Tenure: 4.7yrs
  • Elaine Alec

    Member of Advisory Board

    • Tenure: 0yrs
  • Michael Rigato

    Member of Advisory Board

    • Tenure: 0yrs
  • Matthew Fish

    Director

    • Tenure: 0.4yrs
  • Peter Nguyen

    CFO & Director

    • Tenure: 0.3yrs
  • Matt Christopherson

    Member of Advisory Board

    • Tenure: 0.8yrs

Company Information

ICC International Cannabis Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ICC International Cannabis Corp.
  • Ticker: WRLD.U
  • Exchange: CNSX
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$24.682m
  • Shares outstanding: 705.21m
  • Website: https://www.intlcannabiscorp.com

Location

  • ICC International Cannabis Corp.
  • 789 West Pender Street
  • Suite 810
  • Vancouver
  • British Columbia
  • V6C 1H2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
8K51DB (Deutsche Boerse AG)COM NPV (POST REV SPLT)DEEURNo data
WRLD.UCNSX (Canadian National Stock Exchange)YesCommon SharesCAUSDNov 2014
8K51DB (Deutsche Boerse AG)YesCommon SharesDEEURNov 2014

Biography

ICC International Cannabis Corp., through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and t ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 00:30
End of Day Share Price2019/10/16 00:00
Earnings2019/05/31
Annual Earnings2019/02/28


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.